NXRA Stock Overview
Nextera Enterprises, Inc., through its subsidiary, W Lab Acquisition Corp., develops and markets consumer products that offer solutions to niche personal care needs.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Nextera Enterprises, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.000001 |
| 52 Week High | US$0.00001 |
| 52 Week Low | US$0.000001 |
| Beta | 0 |
| 1 Month Change | n/a |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | -99.90% |
| 5 Year Change | 0% |
| Change since IPO | -100.00% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
| NXRA | US Personal Products | US Market | |
|---|---|---|---|
| 7D | 0% | -6.1% | -3.5% |
| 1Y | n/a | -35.3% | 20.2% |
Return vs Industry: Insufficient data to determine how NXRA performed against the US Personal Products industry.
Return vs Market: Insufficient data to determine how NXRA performed against the US Market.
Price Volatility
| NXRA volatility | |
|---|---|
| NXRA Average Weekly Movement | n/a |
| Personal Products Industry Average Movement | 8.3% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.5% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: NXRA has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine NXRA's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1997 | n/a | n/a | n/a |
Nextera Enterprises, Inc., through its subsidiary, W Lab Acquisition Corp., develops and markets consumer products that offer solutions to niche personal care needs. It offers cosmetic remedies for spider veins, dark circles, blotchy skin, bruises, stretch marks, sun spots, at home microdermabrasion kit, and deep facial lines under the Vita-K Solution brand. The company, under the DermaFreeze365 brand, offers instant line relaxing formula as an anti-line and wrinkle cream for the face, neck and chest, and lip areas; and offers two anti-aging compounds: Gamma-Amino Butyric Acid, a new ingredient in modern skin care technology, and BioxiLift, which produces a cumulative reduction in the appearance of fine lines and wrinkles.
Nextera Enterprises, Inc. Fundamentals Summary
| NXRA fundamental statistics | |
|---|---|
| Market cap | US$42.00 |
| Earnings (TTM) | -US$15.93m |
| Revenue (TTM) | US$7.94m |
0.0x
P/S Ratio0.0x
P/E RatioIs NXRA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| NXRA income statement (TTM) | |
|---|---|
| Revenue | US$7.94m |
| Cost of Revenue | US$3.91m |
| Gross Profit | US$4.03m |
| Other Expenses | US$19.96m |
| Earnings | -US$15.93m |
Last Reported Earnings
Dec 31, 2007
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did NXRA perform over the long term?
See historical performance and comparison